Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial

Por Khullar, Vik, Cambronero, Javier, Angulo, Javier C, Wooning, Marianne, Blauwet, Mary Beth, Dorrepaal, Caroline, Martin, Nancy E
Publicado em 2013

Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

Por Chapple, Christopher R., Nitti, Victor W., Khullar, Vik, Wyndaele, Jean Jacques, Herschorn, Sender, van Kerrebroeck, Philip, Blauwet, Mary Beth, Siddiqui, Emad
Publicado no World J Urol (2014)